| |
October 8, 2009
Outlined below are the principal changes to several DME MAC Local Coverage Determinations (LCDs) and Policy Articles (PAs) that have been revised and posted. Please review the entire LCD and each related Policy Article for complete information.
Ankle Foot/Knee Ankle Foot Orthosis
LCD
- Revision Effective Date: 12/01/2009
HCPCS CODES AND MODIFIERS:
- Added: GA and GZ modifiers
- Deleted: GY modifier
DOCUMENTATION REQUIREMENTS:
- Added: Instructions for the use of GA and GZ modifiers
Policy Article
- Revision Effective Date: 12/01/2009
NON-MEDICAL NECESSITY COVERAGE AND PAYMENT RULES:
- Added: Information on code A9283
CODING GUIDELINES:
- Revised: Instructions for coding A9283
- Revised: Instructions for code L2770
- Revised: Instructions for coding concentric adjustable torsion joints
- Revised: Instructions for RT/LT modifiers
Knee Orthosis
LCD
- Revision Effective Date: 12/01/2009
HCPCS CODES AND MODIFIERS:
- Added: GA/GZ modifiers
- Revised: RT/LT descriptors
DOCUMENTATION REQUIREMENTS:
- Added: Instructions for GA/GZ modifier use
Policy Article
- Revision Effective Date: 12/01/2009
CODING GUIDELINES:
- Revised: Instructions for code L2770
- Revised: Instructions for coding concentric adjustable torsion joints
- Revised: Instructions for RT/LT modifiers
Nebulizers
LCD
- Revision Effective Date: 12/01/2009
INDICATIONS AND LIMITATIONS OF COVERAGE:
- Added: Language from Program Integrity Manual on timing of refills and shipping of supplies/medications
- Revised: Coverage criteria for long-acting bronchodilators
HCPCS CODES AND MODIFIERS:
- Added: GA and GZ modifiers
- Revised: KX modifier descriptor
ICD-9 CODES:
- Revised: ICD-9 codes that support medical necessity for J7605, J7606
DOCUMENTATION:
- Deleted: KX requirements from J7605 & J7606
- Added: Instructions for use of GA and GZ modifiers
Oral Anticancer Drugs
Policy Article
- Revision Effective Date: 10/01/2009
NON-MEDICAL NECESSITY COVERAGE AND PAYMENT RULES:
- Added: 208.92-209.36, 209.70-209.79 to accepted diagnoses for busulfan, capecitabine, cyclophosphamide, etoposide, melphalan, methotrexate, or temozolomide
CODING GUIDELINES:
ICD-9 CODES THAT ARE COVERED:
- Added: 208.92-209.36, 209.70-209.79 to accepted diagnoses for busulfan, capecitabine, cyclophosphamide, etoposide, melphalan, methotrexate, or temozolomide
Oral Antiemetic Drugs
LCD
- Revision Effective Date: 12/01/2009
HCPCS CODES AND MODIFIERS:
- Added: GA and GZ modifiers
- Revised: KX modifier
DOCUMENTATION REQUIREMENTS:
- Added: Instructions for use of the GA and GZ modifiers
Policy Article
- Revision Effective Date: 10/01/2009
CODING GUIDELINES:
ICD-9 CODES THAT ARE COVERED:
- Added: 208.92 – 209.36, 209.70-209.79
Note: The information contained in this article is only a summary of revisions to LCDs and Policy Articles. For complete information on any topic, you must review the LCD and/or Policy Article. |